As of Sep 21
| -2.62 / -2.10%|
The 19 analysts offering 12-month price forecasts for Alexion Pharmaceuticals Inc have a median target of 165.00, with a high estimate of 188.00 and a low estimate of 123.00. The median estimate represents a +35.26% increase from the last price of 121.99.
The current consensus among 20 polled investment analysts is to Buy stock in Alexion Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.